ArticleVaccines2026

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Kriengkrai Prasert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.